-+ 0.00%
-+ 0.00%
-+ 0.00%

Jefferies Initiates Coverage On Beta Bionics with Buy Rating, Announces Price Target of $30

Benzinga·10/12/2026 12:05:30
Listen to the news
Jefferies analyst Michael Toomey initiates coverage on Beta Bionics (NASDAQ:BBNX) with a Buy rating and announces Price Target of $30.